NovoCure's Total Liabilities rose 1842.26% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1842.26%. This contributed to the annual value of $880.6 million for FY2024, which is 1237.47% up from last year.
According to the latest figures from Q3 2025, NovoCure's Total Liabilities is $1.0 billion, which was up 1842.26% from $896.4 million recorded in Q2 2025.
In the past 5 years, NovoCure's Total Liabilities ranged from a high of $1.0 billion in Q3 2025 and a low of $695.5 million during Q1 2021
For the 5-year period, NovoCure's Total Liabilities averaged around $785.6 million, with its median value being $750.5 million (2022).
As far as peak fluctuations go, NovoCure's Total Liabilities soared by 47033.92% in 2021, and later skyrocketed by 267.85% in 2024.
Quarter analysis of 5 years shows NovoCure's Total Liabilities stood at $729.0 million in 2021, then rose by 2.95% to $750.5 million in 2022, then grew by 4.42% to $783.6 million in 2023, then grew by 12.37% to $880.6 million in 2024, then rose by 15.81% to $1.0 billion in 2025.
Its Total Liabilities stands at $1.0 billion for Q3 2025, versus $896.4 million for Q2 2025 and $886.9 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value